如何以创新，灵活的方法推进细胞和基因疗法

日期：2021年10月28日

时间：上午8:00（PDT），上午11:00（EDT）

Today’s health industry is leveraging new, cutting-edge Cell & Gene Therapies (CGTs) to address a variety of medical illnesses and conditions that presently have no other treatments (e.g., gene therapies and CAR-T cell approaches to fight many types of cancer). Most CGT challenges relate to scalability and manufacturability. The circular CGT supply chain, with its highly personalized and novel therapies, is complex and variable. It requires strict collaboration among R&D, CMOs/CDMOs and hospitals. Most importantly, CGT treatments are “Live Drugs” incorporating ex vivo, in culture and in vivo therapies. This talk will cover the critical, end-to-end manufacturing analytics, laboratory informatics, and process performance reporting solutions required to drive innovation, reduce costs and accelerate Cell & Gene Therapies to patients.

学习目标

网络研讨会将在现场活动后提供无限的点播观看。

LabRoots获ASCLS p.a.c.e®项目批准为临床实验室科学继续教育项目的提供者。通过参加本次网络研讨会，您可以获得1个继续教育学分，一旦您浏览了整个网络研讨会。